@misc{indiciaed454afba2f6b,
  title = {Interleukin-6 trans-signaling is a candidate mechanism to drive progression of human DCCs during periods of clinical latency},
  author = {Werner-Klein, M. and Grujovic, A. and Irlbeck, C. and Obradovic, M. and Hoffmann, M. and Koerkel-Qu, H. and Lu, X. and Treitschke, S. and Koestler, C. and Botteron, C. and Weidele, K. and Werno, C. and Polzer, B. and Kirsch, S. and Guzvic, M. and Warfsmann, J. and Honarnejad, K. and Czyz, Z. and Blochberger, I. and Grunewald, S. and Schneider, E. and Haunschild, G. and Patwary, N. and Guetter, S. and Huber, S. and Buchholz, S. and Ruemmele, P. and Heine, N. and Rose-John, S. and Klein, C. A.},
  year = {2020},
  doi = {10.1101/2020.05.28.121145},
  url = {https://www.biorxiv.org/content/10.1101/2020.05.28.121145v1},
  note = {Source identifier: 10.1101/2020.05.28.121145}
}